Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wellesley Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wellesley Investment Advisors
from 13F filings
Historical chart of Wellesley Investment Advisors investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Wellesley Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Wellesley Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $3.7B | 3.3M | 1152.81 |
| 2025-03-31 | $1.3B | 1.0M | 1257.73 |
| 2024-12-31 | $1.1B | 1.0M | 1081.15 |
| 2024-09-30 | $1.2B | 1.0M | 1191.37 |
| 2024-06-30 | $1.6B | 1.4M | 1112.66 |
More positions owned by Wellesley Investment Advisors
View all positions for Wellesley Investment Advisors
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1